Beijing 302 Hospital

This study is testing a combination of five drugs (venetoclax, azacitidine, cytarabine, idarubicin, and G-CSF) as a first treatment for adults with acute myeloid leukemia (AML) who are healthy enough for strong chemotherapy. The goal is to see how many patients achieve complete r…

This study tests a combination of the drug venetoclax with a standard chemotherapy-like agent, plus an infusion of immune cells from a partially matched donor, for people with intermediate- to high-risk myelodysplastic syndromes (MDS) who cannot have a standard stem cell transpla…

This early-phase study tests whether adding a special type of immune cell infusion to chemotherapy can safely help prepare people with relapsed or refractory leukemia for a stem cell transplant. Only 5 participants will be enrolled to check for side effects like graft-versus-host…

This study tests if a gentle electrical current applied to specific points on the skin (TEAS) can reduce side effects from sedation during a digestive procedure called ERCP. About 130 adults will receive either real or fake TEAS alongside standard sedation. Researchers will measu…